Amarendar Reddy Maddirala

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 11

Top Venues

Journal of medicinal chemistry

Beilstein journal of organic chemistry

Dr Reddy's Laboratories Ltd

University of Toledo (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Dr Reddy's Laboratories Ltd

India

Research Associate :: Process R&D

Education History

University of Toledo

United States

PHD :: Chemistry and Biochemistry

Publications

Amarendar Reddy Maddirala, Kevin Tamadonfar, Jerome S Pinkner, Denise Sanick, Scott J Hultgren, James W Janetka
Discovery of Orally Bioavailable FmlH Lectin Antagonists as Treatment for Urinary Tract Infections. Journal of medicinal chemistry 67 (5) (2024)
Amarendar Reddy Maddirala, Kevin Tamadonfar, Jerome S Pinkner, Denise Sanick, Scott J Hultgren, James W Janetka
Discovery of Orally Bioavailable FmlH Lectin Antagonists as Treatment for Urinary Tract Infections. Journal of medicinal chemistry (2024)
Amarendar Reddy Maddirala, Jerome S Pinkner, Kevin Tamadonfar, Denise Sanick, Scott J Hultgren, James W Janetka
Discovery of Orally Bioavailable FmlH Lectin Antagonists as Treatment for Urinary Tract Infections. Journal of medicinal chemistry (2024)
Amarendar Reddy Maddirala, Kevin Tamadonfar, Jerome S Pinkner, Denise Sanick, Scott J Hultgren, James W Janetka
Discovery of Orally Bioavailable FmlH Lectin Antagonists as Treatment for Urinary Tract Infections. Journal of medicinal chemistry 67 (5) (2024)
Amarendar Reddy Maddirala, Kevin Tamadonfar, Jerome S Pinkner, Denise Sanick, Scott J Hultgren, James W Janetka
Discovery of Orally Bioavailable FmlH Lectin Antagonists as Treatment for Urinary Tract Infections. Journal of medicinal chemistry 67 (5) (2024)
Amarendar Reddy Maddirala, Kevin Tamadonfar, Jerome S Pinkner, Denise Sanick, Scott J Hultgren, James W Janetka
Discovery of Orally Bioavailable FmlH Lectin Antagonists as Treatment for Urinary Tract Infections. Journal of medicinal chemistry 67 (5) (2024)
Amarendar Reddy Maddirala, Kevin Tamadonfar, Jerome S Pinkner, Denise Sanick, Scott J Hultgren, James W Janetka
Discovery of Orally Bioavailable FmlH Lectin Antagonists as Treatment for Urinary Tract Infections. Journal of medicinal chemistry 67 (5) (2024)
Amarendar Reddy Maddirala, Kevin Tamadonfar, Jerome S Pinkner, Denise Sanick, Scott J Hultgren, James W Janetka
Discovery of Orally Bioavailable FmlH Lectin Antagonists as Treatment for Urinary Tract Infections. Journal of medicinal chemistry 67 (5) (2024)
Amarendar Reddy Maddirala, Kevin Tamadonfar, Jerome S Pinkner, Denise Sanick, Scott J Hultgren, James W Janetka
Discovery of Orally Bioavailable FmlH Lectin Antagonists as Treatment for Urinary Tract Infections. Journal of medicinal chemistry (2024)
Amarendar Reddy Maddirala, Roger Klein, Jerome S Pinkner, Vasilios Kalas, Scott J Hultgren, James W Janetka
Biphenyl Gal and GalNAc FmlH Lectin Antagonists of Uropathogenic E. coli (UPEC): Optimization through Iterative Rational Drug Design. Journal of medicinal chemistry 62 (2) (2019)
Amarendar Reddy Maddirala, Peter R Andreana
Methyl isocyanide as a convertible functional group for the synthesis of spirocyclic oxindole γ-lactams via post-Ugi-4CR/transamidation/cyclization in a one-pot, three-step sequence. Beilstein journal of organic chemistry 14 (2018)

Amarendar Reddy Maddirala.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Amarendar Reddy Maddirala